HONG KONG – Claims last year that the Chinese market was due for a massive exodus, particularly in the biotech space, may have been somewhat premature. Both international and domestic investors are actively betting on the country’s pharmaceutical sector.

HONG KONG – Shenyang biotech company 3SBio Inc. rose 2.7 percent on its first day of trading on the Hong Kong Stock Exchange.

HONG KONG & NEW DELHI – Middle East respiratory syndrome (MERS) is in the spotlight across Asia, as researchers search for drugs to fight a virus many fear could be as devastating as SARS was in 2003.

HONG KONG – Shenyang biotech company 3SBio Inc. rose 2.7 percent on its first day of trading on the Hong Kong Stock Exchange.

HONG KONG – A series of initiatives by both government and the private sector could give a powerful boost to genetic research in China.

HONG KONG – A series of initiatives by both government and the private sector could give a powerful boost to genetic research in China.